Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2025
>
Hanmi
Hanmi
Read also
Autism Symptoms in Kids
FDA to Approve New Use of Cancer Drug for Autism Symptoms in Kids
Astellas’ Izervay
Astellas’ Izervay gains conditional approval in Japan for GA treatment
Pfizer buys monthly GLP-1RA
Pfizer buys monthly GLP-1RA developer Metsera for up to $4.9bn
Sanofi's
FDA Extends Review Period of Sanofi's Multiple Sclerosis Drug Filing
